Loading...
COL7A1 Polyclonal Antibody

21820

COL7A1 Polyclonal Antibody

COL7A1 Polyclonal Antibody (catalogue number 21820) is a rabbit-derived primary antibody validated for IHC IF, reactive with Human, Mouse samples. It targets Collagen alpha-1(VII) chain (COL7A1): Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen Supplied in 2 pack sizes, from 50ul at ₪893.28 to 100ul at ₪1,301.17; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human, Mouse
Applications
IHC IF
UniProt ID
Q02388
Gene
COL7A1
Target organism
Homo sapiens
Catalogue number
21820
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Collagen alpha-1(VII) chain (COL7A1) · Homo sapiens

Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen

Subcellular location: Secreted, extracellular space, extracellular matrix, basement membrane

Sequence length: 2944 aa · 295220 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.